Nutriband Inc. NTRB
6.08 USD -0.21 (-3.34%)
At closeNov 4, 2026, 4:00 PM EST
6.08 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
6.00 Day range 6.32
2.80 52-week range 9.19
- YTD
- +33.92%
- 1 year
- +5.19%
- Market cap
- 73.91M
- Revenue (ttm)
- 2.02M
- EPS (ttm)
- -0.51
- Shares out
- 11.11M
- Forward P/E
- -17.30
- YTD return
- +33.92%
- 1-year return
- +5.19%
- Volume
- 24.77K
- Avg volume
- 68.99K
- Open
- 6.19
- Previous close
- 6.29
- Day's range
- 6.00 – 6.32
- 52-week range
- 2.80 – 9.19
- Beta
- 0.42
2Y +0.28 (+4.82%)
Key statistics
- Enterprise value
- 44.16M
- PEG ratio
- 0.00
- Price / sales
- 21.92
- Price / book
- 5.47
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -14.30%
- Free cash flow
- -1.55M
- Total cash
- 8.35M
- Total debt
- 527.92K
- Return on equity
- -60.41%
- Short % of float
- 1.00%
- 50-day average
- 5.30
- 200-day average
- 5.09
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
NTRB Revenue — quarterly 437.51K
NTRB Net income — quarterly -880.56K
NTRB EPS — quarterly -0.07
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 3, 2024 | Oct 1, 2024 | 0.00 | -0.12 | — | — |
| Sep 3, 2024 | Jul 1, 2024 | 0.00 | -0.12 | — | — |
| May 31, 2024 | Apr 1, 2024 | 0.00 | -0.21 | — | — |
| Apr 30, 2024 | Jan 1, 2024 | 0.00 | -0.16 | — | — |
| Dec 12, 2023 | Oct 1, 2023 | 0.00 | -0.22 | — | — |
| Sep 11, 2023 | Jul 1, 2023 | 0.00 | -0.11 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 26, 2022 | Small Cap Consumer Research | main | — | Buy |
About Nutriband Inc.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- nutriband.com
News
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274 
Nutriband Files U.S. Patent Application To Increase Protection For Its AVERSA Abuse Deterrent Transdermal Technology 
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology 
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders 
Head to Head Contrast: ARS Pharmaceuticals (NASDAQ:SPRY) and Nutriband (NASDAQ:NTRB) 
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis 
12 Health Care Stocks Moving In Monday's Pre-Market Session 
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 
12 Health Care Stocks Moving In Friday's Intraday Session 
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
Your note
Sign in to keep a note on NTRB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MELNIK SERGUEI | President | Stock Gift | Mar 5, 2023 | 827,999 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 1.86% | 118,063 | 469.89K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.91% | 58,063 | 231.09K | Sep 29, 2024 |
| UBS Group AG | 0.32% | 20,352 | 81.00K | Sep 29, 2024 |
| Avantax Advisory Services, Inc. | 0.29% | 18,678 | 74.34K | Sep 29, 2024 |
| State Street Corporation | 0.27% | 17,266 | 68.72K | Sep 29, 2024 |
| Farther Finance Advisors, Llc | 0.25% | 16,014 | 63.73K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.13% | 71,575 | 284.87K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.69% | 43,788 | 174.28K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.46% | 29,333 | 116.75K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.16% | 9,882 | 39.33K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 7,260 | 28.89K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.11% | 6,718 | 26.74K | Oct 30, 2024 |